D.C. Mun. Regs. tit. 22, r. 22-C6401

Current through Register 71, No. 45, November 7, 2024
Rule 22-C6401 - GENERAL PROVISIONS
6401.1

A testing laboratory shall not be owned or operated, in whole or in part, by a director, officer, member, incorporator, agent, or employee of a cultivation center or dispensary.

6401.2

No owner, member, manager, employee, or agent of a testing laboratory shall have an ownership interest in, or a direct or indirect financial interest in, a dispensary or cultivation center.

6401.3

A testing laboratory registration shall be valid for one (1) year, and may be renewed as set forth in §§5101.1 of this subtitle.

6401.4

A testing laboratory shall not handle, test, or analyze medical marijuana in the District of Columbia unless the laboratory has been issued a medical marijuana registration by the Board.

6401.5

Medical marijuana products shall be sold only after a representative sample has been tested by a registered testing laboratory and the test results have been uploaded to the District of Columbia's electronic tracking system, which verify the medical marijuana sample has received passing results.

6401.6

No testing laboratory shall operate without a registration issued by the Board.

6401.7

A testing laboratory shall not cultivate, process, manufacture, distribute, provide, or sell medical marijuana in any form.

6401.8

A testing laboratory shall not permit the consumption of medical marijuana in any form on the premises.

6401.9

A testing laboratory shall not share a facility with a cultivation center or dispensary.

6401.10

A testing laboratory shall not falsify, change, modify, or otherwise alter in any way the results of quantitative or other analyses performed on medical marijuana samples or the corresponding certificates of analysis.

6401.11

A testing laboratory shall not employ any sampling methods that do not ensure that a random sample is collected for analysis, or that could provide results that are not representative of a batch or lot from which a sample is taken.

6401.12

A testing laboratory shall not prepare medical marijuana samples in such a manner as to provide results that are not representative of a batch or lot from which a sample is taken.

6401.13

A testing laboratory shall not store medical marijuana in quantities greater than that which is necessary to perform required analysis.

6401.14

A testing laboratory shall not transport medical marijuana in quantities greater than that which is necessary to perform required analysis.

6401.15

A testing laboratory shall not perform analysis on any medical marijuana that has not been obtained from a cultivation center or dispensary registered by the Board.

6401.16

A testing laboratory shall not perform analysis on any medical marijuana that has not been identified in the inventory tracking system.

6401.17

A testing laboratory shall not endorse, advertise, or make claims on behalf of any cultivation center, dispensary, brand or strain of medical marijuana, or brand or type of medical marijuana product.

6401.18

A testing laboratory shall not publish or otherwise release to the public the results of any tests performed pursuant to this subtitle, except aggregated data obtained as part of a research plan that has been approved by the Board.

6401.19

A testing laboratory shall comply with all applicable public health, fire, safety laws and regulations.

D.C. Mun. Regs. tit. 22, r. 22-C6401

Final Rulemaking published at 65 DCR 10217 (8/9/2019); amended by Final Rulemaking published at 71 DCR 2388 (3/8/2024)